Intermittent hormone therapy for prostate cancer inferior to continuous therapy
Sunday, June 3, 2012 - 09:30
in Health & Medicine
An international randomized study finds intermittent androgen-deprivation therapy has some quality-of-life benefits, but overall survival times don’t measure up to those seen with continuous therapy.